# Short Course of Miltefosine and Antimony to Treat Cutaneous Leishmaniasis in Bolivia

> **NCT00537953** · PHASE2 · UNKNOWN · sponsor: **Centro de Investigaciones Bioclínicas de la Fundación Fader**

## Conditions studied

- Cutaneous Leihmaniasis

## Interventions

- **DRUG:** Miltefosine , meglumine antimoniate

## Key facts

- **NCT ID:** NCT00537953
- **Lead sponsor:** Centro de Investigaciones Bioclínicas de la Fundación Fader
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2007-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00537953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00537953, "Short Course of Miltefosine and Antimony to Treat Cutaneous Leishmaniasis in Bolivia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00537953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*